Literature DB >> 23202484

Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.

Surbhi Arya1, Nikhil Kumar, Partha Roy, S M Sondhi.   

Abstract

2-Cyanopyridine (1a), 4-cyanopyridine (1b), 2-cyanopyrazine (1c) on condensation with mono amines (2a-c) and diamines (4a-c) in the presence of sodium methoxide as catalyst gave amidine derivatives (3a-i) and bis amidine derivatives (5a-i) in good yields. All these compounds were fully characterized by spectroscopic means and elemental analysis. On screening for anti-inflammatory activity and for in vitro anticancer activity compounds 5c and 5d exhibited good anti-inflammatory activity whereas compounds 5d breast (T47D), 5h, 5i lung (NCI H-522), 5i colon (HCT-15), 3c, 3h, 5i ovary (PA-1) and 3c, 5b, 5h liver (HepG2) exhibited good anticancer activity.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202484     DOI: 10.1016/j.ejmech.2012.10.046

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Synthesis of N-substituted aryl amidines by strong base activation of amines.

Authors:  Muhammad M Khalifa; Micah J Bodner; J Andrew Berglund; Michael M Haley
Journal:  Tetrahedron Lett       Date:  2015-07-01       Impact factor: 2.415

2.  Synthesis, anti-inflammatory, and antiproliferative activity evaluation of isoindole, pyrrolopyrazine, benzimidazoisoindole, and benzimidazopyrrolopyrazine derivatives.

Authors:  Sandeep Kumar; Nikhil Kumar; Partha Roy; Sham M Sondhi
Journal:  Mol Divers       Date:  2013-08-27       Impact factor: 2.943

3.  Mild Reductive Functionalization of Amides into N-Sulfonylformamidines.

Authors:  Paz Trillo; Tove Slagbrand; Fredrik Tinnis; Hans Adolfsson
Journal:  ChemistryOpen       Date:  2017-07-03       Impact factor: 2.911

4.  Rapid and efficient synthesis of formamidines in a catalyst-free and solvent-free system.

Authors:  Zitong Zhou; Yu Zhao; Donghua Zhou; Li Li; Hui Luo; Liao Cui; Weiguang Yang
Journal:  RSC Adv       Date:  2021-10-18       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.